Exchange-traded products

Stepping on the brakes

Much like other structured products that came of age during the past decade, the market crash of 2008 was the first serious test of how exchange-traded funds would react in a bear market. But while the surge in issuance has continued in Europe and Asia,…

Claymore commences on Arca with 21 ETFs

NYSE Arca has started trading 21 Claymore exchange-traded funds (ETFs) after they were transferred from NYSE Alternext US, the former American Stock Exchange. The 21 ETFs cover a range of underlying asset classes, from emerging market countries to water…

ETF Securities emits first Carbon ETC in Europe

ETF Securities (ETFS) has listed the first carbon exchange-traded commodity (ETC) on the London Stock Exchange (LSE) offering exposure to the carbon emissions allowance futures market for the first time in Europe. ETFS Carbon tracks the ICE ECX EUA…

MSCI blends frontier and emerging markets

Index provider MSCI Barra has launched the MSCI Frontier Emerging Markets Index, and a more tradable proxy the Frontier Emerging Markets Apex Index. The indexes are designed to underlie structured products and other financial instruments such as ETFs.

Exchanging places?

Assets under management in European-domiciled mutual funds have plunged more than EUR60 billion this year, while exchange-traded funds have seen healthy capital inflows of over EUR20 billion. With the pattern repeated in the US as traditional asset…

SPA ETF distributes ETF in Portugal

SPA ETF, a provider of exchange-traded funds (ETFs) has partnered with NYSE Euronext and the Portuguese bank Caixa–Banco de Investimento (CaixaBI) to list and distribute the first ETF in Portugal. The SPA ETF PSI-20 is listed on the NYSE Euronext in…

SG Excels with ETFs

Société Générale Acceptance has launched the SG Excel Notes Series 37, which is designed to provide exposure to the economic development of China and Hong Kong through three ETFs.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here